The safety of long-acting β(2) agonist (LABA) therapy in asthma remains controversial but no large scale analyses have been published of LABA safety in children.
Arch Dis Child. 2010 Dec;95(12):1047-53
Authors: Price JF, Radner F, Lenney W, Lindberg B
Read Full Article
